RO is a digital health company that specializes in providing solutions for men's health issues, with a particular focus on treating premature ejaculation. The company offers personalized treatment plans, doctor consultations, and prescribed medication delivered discreetly to patients.

Workpath

Modern Fertility

Ro is a direct-to-patient healthcare company providing high-quality, affordable healthcare without the need for insurance. Ro is the only company to seamlessly connect telehealth and in-home care, diagnostics, labs, and pharmacy services nationwide. This is enabled by Ro’s vertically integrated platform that powers a personalized, end-to-end healthcare experience from diagnosis, to delivery of medication, to ongoing care. Since 2017, Ro has facilitated more than eight million digital healthcare visits in nearly every county in the United States, including 98% of primary care deserts. Ro also provides its patient-centric solutions including Workpath, its in-home care API, and Kit, its at-home diagnostic testing service, to other healthcare companies.

Our CEO, Zachariah Reitano joined Sara Eisen and Frank Holland on CNBC's Money Movers today to talk about the rapid growth of the GLP-1 market and Ro’s plans for 2024.

Watch the full segment here: https://lnkd.in/eZf9sY3a

#obesitycare #telehealth #chroniccare

You can now stream Big Shot: The Ozempic Revolution on Peacock! 

The documentary showcases the impact of GLP-1s and how Ro is supporting patients with high-quality obesity care via telehealth.

#documentary #glp1s

Hello, New York City! 👋 Have you spotted Ro Sparks while commuting through Penn Station? 

A direct result of patient feedback and insights, Ro Sparks is our newest product to support patients living with erectile dysfunction (ED). Our patients asked for a fast-acting, long-lasting, convenient option that allows them to be spontaneous with their partners. 

Sparks is a sublingual (dissolves under the tongue) treatment that works fast, lasts 36 hours, and is not impacted by food intake.

#sexualhealth #patientcentric #OOH

Our CEO, Zachariah Reitano joined Bob Safian for a new episode of the Masters of Scale Rapid Response podcast.

Zach shared how listening to what our patients want and seeing his own father's experience inspired Ro to build the Body Program. 

Listen to the full episode for a wide-ranging conversation on Ro’s belief in the promise and impact of GLP-1s, our ability to help address weight stigma, and how the Body Program expands access to high-quality obesity care. Listen to the full conversation here: https://lnkd.in/g3FzxjrP

Zachariah Reitano, Ro's CEO, shared with Men's Health some tips and lessons learned from his years leading our team.

Read for his insights on receiving feedback, working hard, and moving quickly: https://lnkd.in/eAZ_gXYF

msh id	CO:RO
symbol	-
name	RO
homepage url	https://ro.co
country	US
sector	Healthcare & Health Services
industry	Healthcare
market	PRIVATE
employee count	884
crunchbase url	https://www.crunchbase.com/organization/roman-2
linkedin url	https://www.linkedin.com/company/ro
founders	-

market cap	-
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-
growth cost of revenue	-
growth depreciation and amortization	-
growth ebitda	-
growth ebitda ratio	-
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	-
growth gross profit ratio	-

CO:RO

RO

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	-
cost of revenue	-
depreciation and amortization	-
ebitda	-
ebitda ratio	-
eps	-
eps diluted	-
operating expenses	-
operating income	-
operating income ratio	-

accounts receivables	-
capital expenditure	-
cash at beginning of period	-
cash at end of period	-
inventory	-
working capital ttm	-

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-